
The Venous Thromboembolism Treatment Market was valued at USD 1.05 billion in 2023 and is projected to reach USD 2.13 billion by 2032, registering a CAGR of 8.50% over the forecast period of 2024-2032. The rising prevalence of venous thromboembolism (VTE), increasing awareness regarding early diagnosis and treatment, and advancements in anticoagulant therapies are driving the market's growth. Ad..